| C08CA13 |
Lercanidipine |
Lercanicon |
Film coated tablet |
10 |
mg |
30 |
Фармаконс АД, България |
10 |
mg |
- |
11.28 |
0.188 |
5.64 |
50% |
2.82 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-17011/19.10.2018 |
02.12.2018 |
|
|
Активен |
15841 |
| C08CA13 |
Lercanidipine |
Lercanicon |
Film coated tablet |
10 |
mg |
30 |
Фармаконс АД, България |
10 |
mg |
- |
6.94 |
0.14067 |
4.22 |
50% |
2.11 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13735/12.09.2017; НСР-16085/05.07.2018 |
02.08.2018 |
|
|
Заличен |
15841 |
| C08CA13 |
Lercanidipine |
Renovia |
Film coated tablet |
20 |
mg |
60 |
Berlin - Chemie AG, Германия |
10 |
mg |
- |
27.64 |
0.188 |
22.56 |
50% |
11.28 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-14444/17.11.2017 |
02.08.2018 |
|
|
Активен |
15932 |
| C08CA13 |
Lercanidipine |
RENOVIA |
Film coated tablet |
10 |
mg |
60 |
Berlin-Chemie AG (Menarini Group), Германия |
10 |
mg |
- |
16.93 |
0.188 |
11.28 |
50% |
5.64 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 162/ 20.04.2011 |
02.08.2018 |
08.09.2012 |
|
Активен |
1033 |
| C08CA13 |
Lercanidipine |
TevaLer |
Film coated tablet |
10 |
mg |
30 |
Teva B.V., Нидерландия |
10 |
mg |
- |
9.2 |
0.188 |
5.64 |
50% |
2.82 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
HCР-431/03.07.2013.; НСР-17414/06.12.2018 |
02.01.2019 |
|
|
Активен |
1937 |
| C08CA13 |
Lercanidipine |
TevaLer |
Film coated tablet |
20 |
mg |
30 |
Teva B.V., Нидерландия |
10 |
mg |
- |
13.42 |
0.188 |
11.28 |
50% |
5.64 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
HCР-431/03.07.2013.; КП-90/30.10.2018 и НСР-16742/07.09.2018; НСР-17415/06.12.2018 |
02.01.2019 |
|
|
Активен |
1936 |
| C08DA01 |
Verapamil Hydrochloride |
C08DA01 Verapamil Hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08DA01 |
Verapamil |
Isocor |
Film coated tablet |
80 |
mg |
30 |
Софарма АД, България |
240 |
mg |
- |
2.3 |
0.23 |
2.3 |
25% |
0.58 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-18082/01.03.2019 |
02.04.2019 |
08.09.2012 |
|
Заличен |
180 |
| C08DA01 |
Verapamil |
Isoptin |
Film coated tablet |
80 |
mg |
50 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
6.71 |
0.23035 |
3.84 |
25% |
0.96 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-3796/16.06.2014; КП-43/05.03.2015 и НСР-3327/24.04.2014; пром.на обстоят.НСР-8196/22.02.2016; НСР-9613/23.06.2016 и КП-102/29.08.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
3655 |
| C08DA01 |
Verapamil |
Isoptin |
Film coated tablet |
40 |
mg |
50 |
Abbott GmbH & Co KG, Германия |
240 |
mg |
- |
3.88 |
0.23 |
1.92 |
25% |
0.48 |
|
I10,I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-7138/24.09.2015 |
16.10.2015 |
08.09.2012 |
|
Заличен |
451 |
| C08DA01 |
Verapamil |
Isoptin SR |
Prolonged release tablet |
240 |
mg |
50 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
25.85 |
0.23035 |
11.52 |
25% |
2.88 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-3798/16.06.2014; пром.на обстоят.НСР-8197/22.02.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
452 |
| C08DA01 |
Verapamil |
Isoptin SR |
Prolonged release tablet |
240 |
mg |
20 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
8.64 |
0.23035 |
4.61 |
25% |
1.15 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
КЦРР-560/04.05.2012 г.; НСР-3802/16.06.2014; КП-74/06.03.2015 и НСР-23.07.2014; пром.на обстоят.НСР-8199/22.02.2016; НСР-9637/23.06.2016 и КП-103/29.08.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
3668 |
| C08DA01 |
Verapamil |
Isoptin SR |
Prolonged release tablet |
120 |
mg |
20 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
5.04 |
0.23035 |
2.3 |
25% |
0.57 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
КЦРР-884/28.06.2012 г.; НСР-3797/16.06.2014; пром.на обстоят.НСР-8198/22.02.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
1279 |
| C08DA01 |
Verapamil |
Verapamil Actavis |
Prolonged release tablet |
120 |
mg |
50 |
Актавис EАД, България |
240 |
mg |
- |
5.76 |
0.23 |
5.75 |
25% |
1.44 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
|
02.08.2016 |
08.09.2012 |
|
Заличен |
250 |
| C08DA01 |
Verapamil |
Verapamil Sopharma |
Film coated tablet |
40 |
mg |
50 |
Софарма АД, България |
240 |
mg |
- |
2.99 |
0.23035 |
1.92 |
25% |
0.48 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
|
02.04.2019 |
08.09.2012 |
|
Активен |
179 |
| C08DA01 |
Verapamil |
Verapamil Sopharma |
Film coated tablet |
80 |
mg |
50 |
Софарма АД, България |
240 |
mg |
- |
3.84 |
0.23035 |
3.84 |
25% |
0.96 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
№35/21.08.2009; НСР-17489/13.12.2018 |
02.04.2019 |
08.09.2012 |
16.11.2013 |
Активен |
126 |
| C08DA01 |
Verapamil |
Verapamil-Tchaikapharma |
Coated tablet |
80 |
mg |
50 |
Чайкафарма Висококачествените лекарства АД, България |
240 |
mg |
- |
4.24 |
0.23035 |
3.84 |
25% |
0.96 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-2956/07.03.2014; НСР-18346/05.04.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
2605 |
| C08DA01 |
Verapamil |
Verapamil-Tchaikapharma |
Coated tablet |
40 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
240 |
mg |
- |
2.3 |
0.23035 |
1.15 |
25% |
0.28 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-2494/24.01.2014; НСР-3160/26.03.2014; КП-51/21.06.2018 и НСР-15498/26.04.2018 |
02.04.2019 |
08.09.2012 |
|
Активен |
2533 |
| C08DA01 |
Verapamil |
Verapamil-Tchaikapharma |
Prolonged release tablet |
240 |
mg |
20 |
Чайкафарма Висококачествените лекарства АД, България |
240 |
mg |
- |
5.09 |
0.23035 |
4.61 |
25% |
1.15 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-2495/24.01.2014; НСР-18197/19.03.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
2532 |
| C08DA01 |
Verapamil |
VEROGALID ER 240 MG |
Prolonged release tablet |
240 |
mg |
30 |
Teva B.V., Нидерландия |
240 |
mg |
- |
10.01 |
0.23035 |
6.91 |
25% |
1.72 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
2016-06-02; НСР-17761/17.01.2019 |
02.04.2019 |
08.09.2012 |
|
Активен |
664 |
| C08DA51 |
Verapamil, combinations |
C08DA51 Verapamil, combinations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08DA51 |
Verapamil, Trandolapril |
TARKA |
Modified release tablet |
180 mg/ 2 mg |
mg |
28 |
Mylan Healthcare GmbH, Германия |
1 |
tabl |
- |
20.36 |
0.42276 |
11.84 |
50% |
5.92 |
|
I10,I11.9,I12.9,I13.1 |
№ 175/ 01.06.2011; КЦРР-563/04.05.2012 г.; НСР-4208/30.07.2014; КП-75/06.03.2015 и НСР-4131/23.07.2014; КП-223/11.05.2015 и НСР-5578/05.02.2015; НСР-7937/28.01.2016.; КП-35/29.05.2018 и НСР-15069/23.02.2018 |
02.04.2019 |
08.09.2012 |
|
Активен |
3888 |
| C08DA51 |
Verapamil, Trandolapril |
TARKA |
Modified release tablet |
240 mg/ 4 mg |
mg |
28 |
Mylan Healthcare GmbH, Германия |
1 |
tabl |
- |
31.98 |
0.73035 |
20.45 |
50% |
10.22 |
|
I10,I11.9,I12.9,I13.1 |
№ 208/ 04.11.2011; НСР-4194/30.07.2014; КП-206/30.04.2015 и НСР-5046/17.11.2014; НСР-6202/21.05.2015.; НСР-7930/28.01.2016.; КП-141/08.11.2017 и НСР-13546/18.08.2017 |
02.04.2019 |
08.09.2012 |
|
Активен |
3889 |
| C08DA51 |
Verapamil, Trandolapril |
TARKA |
Modified release tablet |
240 mg/ 2 mg |
mg |
28 |
Mylan Healthcare GmbH, Германия |
1 |
tabl |
- |
25.39 |
0.48035 |
13.45 |
50% |
6.72 |
|
I10,I11.9,I12.9,I13.1 |
№ 199/ 20.09.2011; КЦРР-2826/20.03.2013 и КП-256/11.12.2013; НСР-4207/30.07.2014.; НСР-7929/28.01.2016. |
02.04.2019 |
08.09.2012 |
|
Активен |
2552 |
| C08DB01 |
Diltiazem |
C08DB01 Diltiazem |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|